2-(Piperidin-3-yl)acetamide hydrochloride, 95%, 250mg

2,5-Dichlorophenylboronic acid, 97.0%, 100g

[1-(2-Chloro-acetyl)-piperidin-4-ylmethyl]-carbamic acid tert-butyl ester, 95.0%, 250mg

Methyl 5-oxopyrrolidine-3-carboxylate, 95.0%, 25g

2-[(6-chloro-3-pyridazinyl)(methyl)amino]ethanol, 95.0%, 1g

[3-(Aminomethyl)oxetan-3-yl]methanol, 97.0%, 10g

Methyl [(4-fluorobenzyl)sulfanyl]acetate, 97.0%, 5g

Caja criogénica sin división, 5 Pieza(s)

Recipiente de cristalización DURAN® sin pico, 2000 ml, 190 mm, 1 Pieza

(2-Pyridin-2-yl-benzoimidazol-1-yl)-acetic acid, 95.0%, 250mg

2-(9,9'-Spirobi[fluoren]-2-yl)-4,6-diphenyl-1,3,5-triazine>98.0%(HPLC)1g

Oxetan-3-ylmethanol, 95.0%, 1g

1-[(Prop-2-en-1-ylsulfanyl)methyl]-1H-1,2,3-benzotriazole, 89.0%, 250mg